Table 1.
Selected (putative) pathofunctions of gut microbiota and associated diseases
| Pathofunction | Mode | Associated disease | References |
|---|---|---|---|
| TMA(O) | Metabolite | CVD, T2D, kidney disease | [8, 9] |
| LCA/DCA | Metabolite | CRC, liver cancer | [13] |
| Hydrogen sulfide | Metabolite | IBD, pouchitis, CRC | [19, 20] |
| Indole/phenol/p-cresol | Metabolite | IBD, CVD, renal failure | [54] |
| N-Nitrosamine | Metabolite | Stomach cancer | [55] |
| Ammonia | Metabolite | Several conditions (e.g., hepatic encephalopathy) | [56] |
| Branched-chain amino acids | Metabolite | Obesity-associated insulin resistance | [37] |
| 4-Ethylphenylsulfate | Metabolite | Neurodevelopmental disorders | [57] |
| Uric acid | Metabolite | Gout | [58] |
| Bacterial proteases | Enzyme | IBD | [59] |
For displayed metabolites, pathofunctions represent enzymes catalyzing their formation
CRC colorectal cancer, CVD cardiovascular disease, IBD inflammatory bowel disease, LCA/DCA lithocholic/deoxycholic acid, T2D type 2 diabetes, TMA(O) trimethylamine (N-oxide)